MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine

Moira Sauane1, Rahul V Gopalkrishnan, Devanand Sarkar

  • 1Department of Pathology, Herbert Irving Comprehensive Cancer Center, College of Physicians and Surgeons, Columbia University, BB-1501, 630 West 168th Street, New York, NY 10032, USA. ms2280@columbia.edu

Insights

Interleukin-24 (IL-24), formerly melanoma differentiation-associated gene-7 (mda-7), is a cytokine that shows promise as an anti-cancer agent. Research indicates IL-24 effectively induces apoptosis in various cancer cells and tumors.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Melanoma differentiation-associated gene-7 (mda-7) was identified as a gene upregulated in differentiated melanoma cells.
  • Structural and sequence homology identified MDA-7 as a member of the IL-10 cytokine family, subsequently renamed IL-24.

Purpose of the Study:

  • To investigate the biological functions and therapeutic potential of the mda-7/IL-24 gene and its protein product.
  • To characterize the expression patterns and anti-tumoral activities of IL-24.

Main Methods:

  • Cloning via subtraction hybridization.
  • Northern blot analysis for gene expression profiling.
  • Assessment of apoptosis induction in cancer cell lines, xenografts, and clinical trials.

Main Results:

  • mda-7/IL-24 is expressed in immune tissues (spleen, thymus, leukocytes) and normal melanocytes.
  • Homologous genes (FISP in mice, C49A/MOB-5 in rats) exhibit immune-related functions.
  • IL-24 demonstrated significant apoptosis-inducing effects across diverse human cancer cell lines and in vivo models, including Phase I clinical trials.

Conclusions:

  • IL-24 possesses significant cytokine properties and potent anti-cancer effects.
  • The ability of IL-24 to induce apoptosis in cancer cells highlights its potential as a novel therapeutic agent for various malignancies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...